We are live on ! Find out more
HRMY icon

Harmony Biosciences
HRMY

84 hedge funds and large institutions have $790M invested in Harmony Biosciences in 2021 Q2 according to their latest regulatory filings, with 33 funds opening new positions, 32 increasing their positions, 9 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

450% more first-time investments, than exits

New positions opened: 33 | Existing positions closed: 6

256% more repeat investments, than reductions

Existing positions increased: 32 | Existing positions reduced: 9

47% more funds holding

Funds holding: 57 → 84 (+27)

0.92% more ownership

Funds ownership: 48.28% → 49.2% (+0.92%)

0% more funds holding in top 10

Funds holding in top 10: 6 → 6 (0)

13% less capital invested

Capital invested by funds: $907M → $790M (-$117M)

Holders
84
Holders Change
+27
Holders Change %
+47.37%
% of All Funds
1.46%
Holding in Top 10
6
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.1%
New
33
Increased
32
Reduced
9
Closed
6
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
+$30.2M
2
Vanguard Group
Vanguard Group
Pennsylvania
+$10.5M
3
N
Nuveen
North Carolina
+$8.31M
4
State Street
State Street
Massachusetts
+$6.46M
5
PA
Perceptive Advisors
New York
+$5.39M

Top Sellers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
-$69.3M
2
NHAS
Novo Holdings A/S
Denmark
-$57.4M
3
LGM
Logos Global Management
California
-$3.3M
4
MWNA
Marshall Wace North America
New York
-$666K
5
Arrowstreet Capital
Arrowstreet Capital
Massachusetts
-$566K
Name Holding Trade Value Shares
Change 		Change in
Stake
BBA
26
Baker Bros. Advisors
New York
$3.49M – – –
Point72 Asset Management
27
Point72 Asset Management
Connecticut
$3.22M +$3.43M +114,212 New
CI
28
Cambiar Investors
Colorado
$2.94M +$871K +29,035 +39%
RPAM
29
Rhenman & Partners Asset Management
Sweden
$2.82M +$3M +100,000 New
Deutsche Bank
30
Deutsche Bank
Germany
$2.35M +$2.37M +79,142 +1,989%
Norges Bank
31
Norges Bank
Norway
$2.06M +$2.18M +72,800 New
ECM
32
ExodusPoint Capital Management
New York
$2M +$1.24M +41,248 +139%
MWNA
33
Marshall Wace North America
New York
$1.89M -$666K -22,186 -25%
CIBC Private Wealth Group
34
CIBC Private Wealth Group
Georgia
$1.67M +$1.77M +59,000 New
Charles Schwab
35
Charles Schwab
California
$1.34M +$1.01M +33,610 +244%
Bank of New York Mellon
36
Bank of New York Mellon
New York
$1.27M +$962K +32,069 +245%
Citadel Advisors
37
Citadel Advisors
Florida
$1.26M -$180K -6,008 -12%
D.E. Shaw & Co
38
D.E. Shaw & Co
New York
$1.26M +$1.34M +44,765 New
IAM
39
Iridian Asset Management
Connecticut
$1.2M +$1.28M +42,597 New
Squarepoint
40
Squarepoint
New York
$1.07M +$1.14M +38,041 New
Swiss National Bank
41
Swiss National Bank
Switzerland
$1.06M +$1.13M +37,600 New
NFC
42
Northeast Financial Consultants
Connecticut
$999K +$1.06M +35,383 New
CIC
43
Cornercap Investment Counsel
Georgia
$956K +$1.02M +33,853 New
PCM
44
Polaris Capital Management
Massachusetts
$872K +$927K +30,900 New
California State Teachers Retirement System (CalSTRS)
45
California State Teachers Retirement System (CalSTRS)
California
$869K +$642K +21,393 +228%
JF
46
Jump Financial
Illinois
$832K +$659K +21,975 +293%
Goldman Sachs
47
Goldman Sachs
New York
$806K +$442K +14,741 +107%
UBS Group
48
UBS Group
Switzerland
$781K +$615K +20,496 +287%
CSS
49
Cubist Systematic Strategies
Connecticut
$556K +$591K +19,686 New
New York State Common Retirement Fund
50
New York State Common Retirement Fund
New York
$543K +$386K +12,851 +201%
1
2
3 4

HRMY Hedge Fund Activity: Q2 2021 in Review

84 of the 5,745 institutional investors tracked by Wall St. Rank reported a position in Harmony Biosciences (HRMY) for Q2 2021, worth a combined $790M — down 13% from $907M a quarter earlier.

Buyers outnumbered sellers: 33 funds opened new HRMY positions and 6 closed out — a net gain of 27 holders — while 32 added to existing stakes and 9 trimmed.

The largest buyer was BlackRock, adding an estimated $30.2M. The largest seller was Fidelity Investments, cutting an estimated $69.3M.

  • 84 institutional investors held Harmony Biosciences (HRMY) as of Q2 2021, up from 57 in Q1 2021.
  • Funds reported $790M of Harmony Biosciences stock for Q2 2021, down 13% quarter-over-quarter.
  • 33 funds opened new Harmony Biosciences positions in Q2 2021 and 6 closed out, a net change of +27 holders.
  • The largest Harmony Biosciences buyer in Q2 2021 was BlackRock, an estimated $30.2M added.
  • The largest Harmony Biosciences seller in Q2 2021 was Fidelity Investments, an estimated $69.3M sold.

Based on aggregated 13F filings for Q2 2021.